Rare diseases
Investigational molecules
Locations
Back to Poland28 clinical trials in Radom, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)A Phase III Randomized Double‑Blind Study of Elecoglipron for Adults with Type 2 Diabetes on Insulin
PolandA study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes
PolandA Phase III Study of Elecoglipron Compared with Semaglutide for Adults with Type 2 Diabetes Mellitus
PolandStudy on the Safety and Effectiveness of Trastuzumab Deruxtecan vs. Palbociclib-Based Drug Combination for Advanced HR-Positive, HER2-Low Breast Cancer Patients
PolandStudy on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure
PolandStudy on the Effectiveness of Ketoanalogues in Preventing Muscle Loss in Patients with Nephrotic Syndrome
PolandStudy of Three Doses of Frevecitinib (KN-002) in Adults with Severe Asthma Not Controlled by Medium‑to‑High Dose Inhaled Steroid/LABA Therapy
PolandPhase III randomized trial of elecoglipron to assess safety and weight loss in adults with obesity or overweight, with or without type 2 diabetes
PolandA study of mirikizumab levels in breast milk of breastfeeding women with ulcerative colitis or Crohn's disease
PolandEfficacy of intra‑articular allogeneic peripheral blood mononuclear cells induced to an early apoptotic state versus placebo in adults with primary knee osteoarthritis
PolandA study of PF-08634404 and a drug combination in adults with advanced or metastatic non-small cell lung cancer
PolandA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
PolandThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials focusing on non-small cell lung cancer, urothelial cancer, and prostate cancer. Studies are evaluating innovative combination therapies and targeted treatments to improve patient outcomes.
Research includes novel immunotherapy combinations and precision medicine strategies.
Comprehensive research into chronic kidney disease treatments, particularly focusing on patients with high proteinuria. Trials are exploring innovative combination therapies with medications like dapagliflozin.
Studies aim to slow kidney function decline and improve patient outcomes.
Clinical research focusing on Type 2 Diabetes management and treatment optimization. Studies are evaluating new therapeutic options and comparing their effectiveness with established treatments.
Investigations aim to enhance treatment options for patients with inadequate glycemic control.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
